PMVPPMV Pharmaceuticals, Inc.

Nasdaq pmvpharma.com


$ 1.80 $ 0.03 (1.68 %)    

Friday, 31-May-2024 15:59:58 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 1.82
$ 1.76
$ 1.80 x 875
$ 0.00 x 0
$ 1.76 - $ 1.81
$ 1.18 - $ 9.72
457,060
na
93.63M
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-03-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-pmv-pharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

 foundation-medicine-and-pmv-pharma-partner-to-develop-genomic-profiling-for-tp53-mutation-therapy--targets-tp53-mutation-in-advanced-cancers-with-investigational-therapy-rezatapopt

Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ:PMVP, ", PMV Pharma", )))) today announced a partnershi...

 hc-wainwright--co-reiterates-buy-on-pmv-pharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

 craig-hallum-initiates-coverage-on-pmv-pharma-with-buy-rating-announces-price-target-of-6

Craig-Hallum analyst Albert Lowe initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target...

 pmv-pharma-q1-eps-030-beats-037-estimate

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by...

 jefferies-initiates-coverage-on-pmv-pharma-with-buy-rating-announces-price-target-of-5

Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target o...

 pmv-pharmaceuticals-pynnacle-phase-i-data-of-rezatapopt-in-advanced-ovarian-cancer-featured-in-oral-presentation-at-2024-sgo-annual-meeting-on-womens-cancer

Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated pat...

 hc-wainwright--co-reiterates-buy-on-pmv-pharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

 pmv-pharmaceuticals-fy23-eps-144-vs-161-yoy

Fiscal Year 2023 Financial ResultsAs of December 31, 2023, PMV Pharma had $228.6 million in cash, cash equivalents, and marketa...

 pmv-pharmaceuticals-plans-workforce-reduction-of-approximately-30-reveals-prioritization-of-pc14586-development-and-focused-discovery-research-efforts-results

Unaudited cash, cash equivalents, and marketable securities totaling approximately $229 million as of December 31, 2023, combin...

 ladenburg-thalmann-initiates-coverage-on-pmv-pharma-with-buy-rating-announces-price-target-of-7

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Pri...

 recap-pmv-pharma-q3-earnings
Recap: PMV Pharma Q3 Earnings
11/09/2023 13:50:12

 pmv-pharma-q3-eps-034-beats-045-estimate

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by...

 hc-wainwright--co-maintains-buy-on-pmv-pharma-lowers-price-target-to-5

HC Wainwright & Co. analyst Robert Burns maintains PMV Pharma (NASDAQ:PMVP) with a Buy and lowers the price target from ...

 why-belden-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing o...

 precision-oncology-pmv-pharmaceuticals-reveals-early-data-from-cancer-study-in-pretreated-patients

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION